A LEADING MEDICAL RESEARCH INSTITUTE SPECIALISING IN ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Alzheimer’s Research Australia
With Professor Vicky Vass, Chief Executive Officer
ORGANISATIONS IN MEDICAL RESEARCH
Filmed in Perth, Western Australia | November 2024
Professor Vicky Vass serves as the Chief Executive Officer of Alzheimer’s Research Australia, which is based in Perth, Western Australia. Australian Health Journal met with Professor Vass to hear of the organisation’s mission to solve the mysteries surrounding Alzheimer’s disease, and focus on detection as the key to their efforts.
Founded in 1993, the organisation now comprises a large research team, a clinical trials division, and an administrative support team. Their aim is to make Alzheimer’s a distant memory through rigorous research.
Their philosophy revolves around operating as one cohesive team, which includes all these parts as well as the board, fostering effective collaboration. Leading this team is Professor Ralph Martins AO, as the Chief Inspector in their mission. He focuses on uncovering pathways for prevention, intervention, and the latest treatments for neurodegenerative diseases.
Among the key studies highlighted by Professor Vass is the blood biomarker study led by Professor Ralph Martins, which aims to develop a cost-effective method for detecting Alzheimer’s through a simple blood test. Currently, detection methods involve multiple scans and intense processes, but this initiative could transform the landscape by making detection more accessible and affordable.
Another study is run by Dr. Prashant Bharadwaj who heads the research on childhood dementia, focusing on providing hope to the youngest patients affected by these debilitating diseases. His work is dedicated to ensuring that children have a future filled with memories rather than loss, striving to find ways to detect and ultimately cure childhood dementia.
The board of Alzheimer’s Research Australia comprises a diverse group of individuals, including academics and those involved in commercial work and aged care. The common goal uniting them is to find a cure for Alzheimer’s disease. Funding for the organisation primarily comes from donations and rely heavily on this support, as they do not receive significant government funding, although they do get some grants for research.
Professor Vass describes Alzheimer’s Research Australia as an incredible place to work, boasting a community akin to a family. Every role within the organisation is respected, contributing to a common goal of making Alzheimer’s a distant memory for future generations.
-
Reflecting on a pivotal year for pharmacy
Dr. Kate Wang, a Senior Lecturer in Pharmacy at RMIT University and Adjunct Senior Lecturer, University of Western Australia, has over a decade of experience in both hospital and community pharmacy settings.
Dr Wang spoke to Australian Health Journal on some of the key topics in 2024 that have been pivotal as a pharmacist, academic and researcher for the pharmacy profession.
-
Analogy of the system, rather than the ED front door
“The problem of blockages shows up in ambulance ramping and long wait times, but this is a complex issue requiring whole-of-health system solutions,” according to Professor Hugh Grantham, Chair of Emergency Medicine Foundation in an interview with Australian Health Journal.
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
